It is generally thought that infection of the central nervous system (CNS)
by HIV-1 can occur early, even around the time of seroconversion, and evide
nce from animal studies supports this. However, the mode and timing. of vir
al entry remain poorly understood since there have been comparatively few s
tudies of the early neuropathology of HIV infection. In this study, samples
of frontal and temporal lobes, and basal ganglia, were selected from 12 HI
V-positive drug users who had been infected for 4-130 months before death,
10 HIV-negative drug users and 10 non-drug using controls, all age and sex
matched. Routine and immunocytochemical staining showed that leptomeningeal
and perivascular lymphocytic infiltrate was upregulated in HIV-infected ca
ses compared with the two control groups, and choroid plexitis was confined
to the HIV-positive subjects, suggesting an association with viral infecti
on. In contrast, CD68-positive microglia were enhanced in both HIV-positive
and HIV-negative drug users, considerably above the baseline seen in norma
l controls. However, there was no statistical difference between the three
groups in relation to astrocytes. Screening and competitive polymerase chai
n reaction (PCR) undertaken on multiple samples including brain tissue, cho
roid plexus and leptomeninges from four of the HIV-positive subjects and on
e control case showed that the pro-viral burden was never more than 13 copi
es/mu g DNA and was negative in multiple samples from one HIV-positive case
and one control case. All the basal ganglia samples were PCR-negative. Thi
s study has not revealed any 'hot spots' of viral load in brain tissue, cho
roid plexus or meninges, either early or late in the course of presymptomat
ic HIV infection. Drug use alone is associated with significant upregulatio
n of microglia and this may predispose to HIV infection of the nervous syst
em in drug users.